Jill U. Adams is a freelance science journalist based in Albany, New York. She covers health, mental health and biomedical research for such publications as The Transmitter, The Washington Post, Scientific American, Undark and The Scientist. She has a Ph.D. in pharmacology from Emory University in Atlanta, Georgia.
Jill Adams
Contributing writer
From this contributor
Gene variants accumulate in older men’s sperm; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 20 October.
Gene variants accumulate in older men’s sperm; and more
By
Jill Adams
21 October 2025 | 2 min read
Parsing phenotypes in people with shared autism-linked variants; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 13 October.
Parsing phenotypes in people with shared autism-linked variants; and more
By
Jill Adams
14 October 2025 | 2 min read
ADSI, leucovorin, autism registry; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 October.
Tylenol, leucovorin and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 29 September.
Impaired sensory learning in a mouse model of fragile X syndrome; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 September.
Impaired sensory learning in a mouse model of fragile X syndrome; and more
By
Jill Adams
23 September 2025 | 2 min read
Explore more from The Transmitter
The missing half of the neurodynamical systems theory
Bifurcations—an underexplored concept in neuroscience—can help explain how small differences in neural circuits give rise to entirely novel functions.
The missing half of the neurodynamical systems theory
Bifurcations—an underexplored concept in neuroscience—can help explain how small differences in neural circuits give rise to entirely novel functions.
By
Xiao-Jing Wang
27 October 2025 | 8 min read
Remembering GABA pioneer Edward Kravitz
The biochemist, who died last month at age 92, was part of the first neurobiology department in the world and showed that gamma-aminobutyric acid is inhibitory.
Remembering GABA pioneer Edward Kravitz
The biochemist, who died last month at age 92, was part of the first neurobiology department in the world and showed that gamma-aminobutyric acid is inhibitory.
By
Claudia López Lloreda
24 October 2025 | 9 min listen
Protein tug-of-war controls pace of synaptic development, sets human brains apart
Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.
Protein tug-of-war controls pace of synaptic development, sets human brains apart
Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.
By
Holly Barker
23 October 2025 | 9 min listen